Cargando…

MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial

BACKGROUND AND PURPOSE: Treatments to facilitate recovery after traumatic brain injury (TBI) are urgently needed. We conducted a 9‐month pilot, randomized placebo‐controlled clinical trial to examine the safety and potential effects of the herbal supplement MLC901 (NeuroAiD II™) on cognitive functio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theadom, A., Barker‐Collo, S., Jones, K. M., Parmar, P., Bhattacharjee, R., Feigin, V. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055867/ https://www.ncbi.nlm.nih.gov/pubmed/29611892 http://dx.doi.org/10.1111/ene.13653

Ejemplares similares

Safety and Use of MLC601/MLC901 (NeuroAiD(TM)) in Primary Intracerebral Hemorrhage: A Cohort Study from the NeuroAiD Safe Treatment Registry
por: Kumar, Ramesh, et al.
Publicado: (2020)

Systematic Review and Meta-Analysis of the Efficacy of MLC901 (NeuroAiD II(TM)) for Acute Ischemic Brain Injury in Animal Models
por: Ranuh, I. G. M. Aswin R., et al.
Publicado: (2021)

The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients
por: Navarro, Jose C., et al.
Publicado: (2012)

Clinical Outcomes of MLC601 (NeuroAiD(TM)) in Traumatic Brain Injury: A Pilot Study
por: Al Fauzi, Asra, et al.
Publicado: (2020)

NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo‐controlled randomized trial
por: Chen, Christopher L. H., et al.
Publicado: (2021)

Role of MLC901 in increasing neurogenesis in rats with traumatic brain injury
por: Rosyidi, Rohadi Muhammad, et al.
Publicado: (2020)

The value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD)
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2015)

The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
por: Chen, Christopher L.H., et al.
Publicado: (2019)

Positive effects of the traditional Chinese medicine MLC901 in cognitive tasks
por: Lorivel, T., et al.
Publicado: (2015)

The NeuroAiD Safe Treatment (NeST) Registry: a protocol
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2015)

Population-based cohort study of the impacts of mild traumatic brain injury in adults four years post-injury
por: Theadom, Alice, et al.
Publicado: (2018)

Sex differences in outcomes from mild traumatic brain injury eight years post-injury
por: Starkey, Nicola Jayne, et al.
Publicado: (2022)

Contribution of CNS cells in NeuroAIDS
por: Verma, Ashish Swarup, et al.
Publicado: (2010)

Ischemic Stroke and Savings in Time to Achieve Functional Recovery: Experience from NeuroAiD
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2023)

Randomised, double-blind, placebo-controlled study investigating Safety and efficAcy of MLC901 in post-traUmatic bRAin Injury: the SAMURAI study protocol
por: Pilipenko, Pavel, et al.
Publicado: (2022)

Opiate Drug Use and the Pathophysiology of NeuroAIDS
por: Hauser, Kurt F, et al.
Publicado: (2012)

Role of Biosensing Technology for NeuroAIDS Management
por: Jayant, RD, et al.
Publicado: (2016)

Spinal Cord Injury—Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury
por: Kumar, Ramesh, et al.
Publicado: (2016)

Distinguishing between enduring and dynamic concussion symptoms: applying Generalisability Theory to the Rivermead Post Concussion Symptoms Questionnaire (RPQ)
por: Medvedev, Oleg N., et al.
Publicado: (2018)

Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug Abusers
por: Jayant, Rahul Dev, et al.
Publicado: (2018)

Parent and Teacher-Reported Child Outcomes Seven Years After Mild Traumatic Brain Injury: A Nested Case Control Study
por: Jones, Kelly M., et al.
Publicado: (2021)

MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study
por: Pakdaman, Hossein, et al.
Publicado: (2023)

Molecular epigenetics, chromatin, and NeuroAIDS/HIV: Translational implications
por: Shapshak, Paul, et al.
Publicado: (2008)

Molecular epigenetics, chromatin, and NeuroAIDS/HIV: Immunopathological implications
por: Chiappelli, Francesco, et al.
Publicado: (2008)

NIMH funding opportunities for NeuroAIDS therapeutics development research
por: Bao, Jing, et al.
Publicado: (2006)

Sustained-release nanoART formulation for the treatment of neuroAIDS
por: Jayant, Rahul Dev, et al.
Publicado: (2015)

Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
por: Sarma, Anupam, et al.
Publicado: (2020)

The Traditional Chinese Medicine MLC901 inhibits inflammation processes after focal cerebral ischemia
por: Widmann, C., et al.
Publicado: (2018)

Advancing research in NeuroAIDS using collaboration and public data sharing
por: Cysique, Lucette A.
Publicado: (2015)

When do models of NeuroAIDS faithfully imitate “the real thing”?
por: Gelman, Benjamin B., et al.
Publicado: (2017)

HIV-Tat regulates macrophage gene expression in the context of neuroAIDS
por: Carvallo, Loreto, et al.
Publicado: (2017)

Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
por: Hu, Guoku, et al.
Publicado: (2017)

Advances in SIV/SHIV Non-Human Primate Models of NeuroAIDS
por: Moretti, Sonia, et al.
Publicado: (2021)

Influence of MLC901 Alone and with Moderate Exercise on Pain Response Concurrent Due to Stress of Male Mice
por: Nasehi, Maryam, et al.
Publicado: (2019)

The role of MLC901 in reducing VEGF as a vascular permeability marker in rats with spinal cord injury
por: Wahyudi, et al.
Publicado: (2022)

Spinal cord injury – assessing tolerability and use of combined rehabilitation and NeuroAiD (SATURN) study – primary results of an exploratory study
por: Kumar, Ramesh, et al.
Publicado: (2022)

The integrated National NeuroAIDS Tissue Consortium database: a rich platform for neuroHIV research
por: Heithoff, Abigail J, et al.
Publicado: (2019)

Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS
por: Campbell, Jennifer H., et al.
Publicado: (2011)

Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse
por: Sagar, Vidya, et al.
Publicado: (2016)

Clathrin-nanoparticles deliver BDNF to hippocampus and enhance neurogenesis, synaptogenesis and cognition in HIV/neuroAIDS mouse model
por: Vitaliano, Gordana D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3vlg0lkkfr8fg9mm6dd9llllrm